BCL2 and lymphoma: Interestingly, antilymphoma activity of hippuristonal was blocked by overexpression of the anti-apoptotic proteins BCL2 or MCL1 and hippuristonal synergized with the BCL2 inhibitor ABT-737 to induce of apoptosis of MYC lymphoma cells in vitro.